» Articles » PMID: 12563178

Genetic Polymorphisms in MDR1 and CYP3A4 Genes in Asians and the Influence of MDR1 Haplotypes on Cyclosporin Disposition in Heart Transplant Recipients

Overview
Specialties Genetics
Pharmacology
Date 2003 Feb 4
PMID 12563178
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Intestinal cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) both play a vital role in the metabolism of oral cyclosporine (CsA). We investigated the genetic polymorphisms in CYP3A4(promoter region and exons 5, 7 and 9) and MDR1 (exons 12, 21 and 26) genes and the impact of these polymorphisms on the pharmacokinetics of oral CsA in stable heart transplant patients (n = 14). CYP3A4 polymorphisms were rare in the Asian population and transplant patients. Haplotype analysis revealed 12 haplotypes in the Chinese, eight in the Malays and 10 in the Indians. T-T-T was the most common haplotype in all ethnic groups. The frequency of the homozygous mutant genotype at all three loci (TT-TT-TT) was highest in the Indians (31%) compared to 19% and 15% in the Chinese and Malays, respectively. In heart transplant patients, CsA exposure (AUC(0-4 h), AUC(0-12 h) and C(max)) was high in patients with the T-T-T haplotypes compared to those with C-G-C haplotypes. These findings suggest that haplotypes rather than genotypes influence CsA disposition in transplant patients.

Citing Articles

Pharmacogenetic Study of the Impact of Single Nucleotide Polymorphisms on the Response to Cyclosporine in Psoriasis Patients.

Chernov A, Kilina D, Smirnova T, Galimova E Pharmaceutics. 2022; 14(11).

PMID: 36432633 PMC: 9693450. DOI: 10.3390/pharmaceutics14112441.


Subset analysis of safety and efficacy in asian patients treated with RRx-001 across three clinical trials.

Guo X, Wang X, Shen S, Oronsky B, Reid T, Stirn M Am J Cancer Res. 2022; 12(9):4448-4457.

PMID: 36225630 PMC: 9548015.


Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib.

Maeda A, Ando H, Irie K, Hashimoto N, Morishige J, Fukushima S Eur J Clin Pharmacol. 2022; 78(8):1239-1247.

PMID: 35527301 DOI: 10.1007/s00228-022-03331-0.


Pharmacogenetics of ATP binding cassette transporter MDR1(1236C>T) gene polymorphism with glioma patients receiving Temozolomide-based chemoradiation therapy in Indian population.

Munisamy M, Munisamy S, Kumar J, Jose A, Thomas L, Baburaj G Pharmacogenomics J. 2021; 21(2):262-272.

PMID: 33589792 DOI: 10.1038/s41397-021-00206-y.


Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.

Wang T, Zhou Y, Cao G Eur J Clin Pharmacol. 2021; 77(8):1095-1111.

PMID: 33515076 DOI: 10.1007/s00228-021-03088-y.